Literature DB >> 22886020

Gray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease.

Seong Hye Choi1, Mikel Olabarrieta, Oscar L Lopez, Victoria Maruca, Steven T Dekosky, Ronald L Hamilton, James T Becker.   

Abstract

Up to 60% of the patients with Alzheimer's disease (AD) can have cortical or brainstem Lewy bodies (LB), and extrapyramidal signs (EPS) have been found to be associated with LB in AD patients. However, the relationship between EPS and brain volumes has not been studied in the LB variant of AD using structural magnetic resonance imaging (MRI). The purpose of this study was to determine the relationship between patterns of brain atrophy and clinical EPS in patients with pathologically confirmed AD. We compared gray matter structure using voxel-based morphometry in 29 Definite AD cases, 16 (55%) of whom also had LBs identified with α-synuclein immunohistochemistry. Multivariate models analyzed brain volume at a voxel level accounting for subject group, Mini-Mental State Examination (MMSE), EPS, total brain volume, and the time from MRI scan to death. There was no significant difference in gray matter volume in the Definite AD patients as a function of LB. There was a significant association between gray matter volumes and the MMSE in AD patients, both with and without LBs. There was a significant correlation between gray matter volume and EPS only in the group of AD patients with LBs, and not in those with pure AD. These findings suggest that that the etiology of EPS in patients with the LB variant of AD is associated with neuronal loss in the nigrostriatal tracts. By contrast, the source of the EPS in AD alone appears to be less well localized.

Entities:  

Mesh:

Year:  2012        PMID: 22886020      PMCID: PMC3589734          DOI: 10.3233/JAD-2012-121108

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  33 in total

1.  Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II.

Authors:  O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

Authors:  O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

3.  Research evaluation and prospective diagnosis of dementia with Lewy bodies.

Authors:  Oscar L Lopez; James T Becker; Daniel I Kaufer; Ronald L Hamilton; Robert A Sweet; William Klunk; Steven T DeKosky
Journal:  Arch Neurol       Date:  2002-01

4.  Thresholding of statistical maps in functional neuroimaging using the false discovery rate.

Authors:  Christopher R Genovese; Nicole A Lazar; Thomas Nichols
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

5.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

6.  Predictors of progression in patients with AD and Lewy bodies.

Authors:  O L Lopez; S Wisniewski; R L Hamilton; J T Becker; D I Kaufer; S T DeKosky
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

7.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

8.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

9.  Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

Authors:  R L Hamilton
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

10.  The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis.

Authors:  J T Becker; F Boller; O L Lopez; J Saxton; K L McGonigle
Journal:  Arch Neurol       Date:  1994-06
View more
  1 in total

Review 1.  Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Exp Gerontol       Date:  2014-09-28       Impact factor: 4.032

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.